Renate Hodge

2.0k total citations · 1 hit paper
11 papers, 568 citations indexed

About

Renate Hodge is a scholar working on Hematology, Biochemistry and Genetics. According to data from OpenAlex, Renate Hodge has authored 11 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Biochemistry and 4 papers in Genetics. Recurrent topics in Renate Hodge's work include Blood transfusion and management (5 papers), Hemoglobinopathies and Related Disorders (4 papers) and Platelet Disorders and Treatments (3 papers). Renate Hodge is often cited by papers focused on Blood transfusion and management (5 papers), Hemoglobinopathies and Related Disorders (4 papers) and Platelet Disorders and Treatments (3 papers). Renate Hodge collaborates with scholars based in United Kingdom, Canada and Netherlands. Renate Hodge's co-authors include Charlotte Llewelyn, Karin Fijnvandraat, Alison Deary, Simon Stanworth, Valerie Hopkins, Ana Sabrina Mora, Cara Hudson, Angela D’Amore, Paul Clarke and Rizwan Khan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Renate Hodge

11 papers receiving 552 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Platelet-Transfusion Thresholds in Neonates

2018 249 citations Anna Curley, Simon Stanworth et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Renate Hodge

Since Specialization

Citations

This map shows the geographic impact of Renate Hodge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate Hodge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate Hodge more than expected).

Fields of papers citing papers by Renate Hodge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renate Hodge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate Hodge. The network helps show where Renate Hodge may publish in the future.

Co-authorship network of co-authors of Renate Hodge

This figure shows the co-authorship network connecting the top 25 collaborators of Renate Hodge. A scholar is included among the top collaborators of Renate Hodge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renate Hodge. Renate Hodge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients 2024 ·BMJ Open ·Amy Evans, (unknown), Helen Thomas, Katie Keen, Christopher J.E. Watson, Daniel F. McAuley, Guy A. MacGowan, Neil Sheerin, Andrew J. Fisher, James Shaw, (unknown), Andrea Fallow, Daphne Kounali, Jennifer Banks, Margaret Stevens, (unknown), Renate Hodge, (unknown), Daniel Harvey, John H. Dark	2
2	Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double‐blind, placebo‐controlled feasibility trial 2024 ·SHILAP Revista de lepidopterología ·Michael Desborough, Emma Laing, Daphne Kounali, Ana Sabrina Mora, Renate Hodge, (unknown), Helen Thomas, Cara Hudson, (unknown), Akshay Shah, Paula Hutton, (unknown), Matt P. Wise, Matt Morgan, Stuart McKechnie, Simon Stanworth	1
3	Do liberal thresholds for red cell transfusion result in improved quality of life for patients undergoing intensive chemotherapy for acute myeloid leukemia? A randomized crossover feasibility study 2022 ·Haematologica ·(unknown), Mallika Sekhar, (unknown), Ana Sabrina Mora, Renate Hodge, Cara Hudson, (unknown), Valerie Hopkins, Simon Stanworth	4
4	An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial 2020 ·Blood ·Judith Marsh, Simon Stanworth, Laura Pankhurst, Delordson Kallon, (unknown), (unknown), Alison Deary, Ana Sabrina Mora, Joanne Brown, Emma Laing, Louise Choo, Renate Hodge, Charlotte Llewelyn, (unknown), (unknown), Aleksandar Mijović, Ghulam J. Mufti, Cristina Navarrete, Colin Brown	24
5	Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial 2020 ·British Journal of Haematology ·Simon Stanworth, Sally Killick, Zoe McQuilten, Μαρίνα Καρακάντζα, Robert Weinkove, (unknown), Laura Pankhurst, Renate Hodge, Valerie Hopkins, Helen Thomas, Alison Deary, Jeannie Callum, Yulia Lin, Erica M. Wood, Rena Buckstein, David Bowen, (unknown)	49
6	Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial 2018 ·Critical Care ·Nicola Curry, Claire Foley, Henna Wong, Ana Sabrina Mora, Elinor Curnow, (unknown), Renate Hodge, Valerie Hopkins, Alison Deary, (unknown), Phil Moss, Matthew J. Reed, (unknown), Ross Davenport, Simon Stanworth	72
7	A Feasibility Randomized Trial of Red Cell Transfusion Thresholds in Myelodysplasia 2018 ·Blood ·Simon Stanworth, Sally Killick, Zoe McQuilten, Μαρίνα Καρακάντζα, (unknown), Laura Pankhurst, Renate Hodge, Valerie Hopkins, Helen Thomas, Alison Deary, Rena Buckstein, Jeannie Callum, Yulia Lin, David Bowen	2
8	Randomized Trial of Platelet-Transfusion Thresholds in Neonates breakdown → 2018 ·New England Journal of Medicine ·Anna Curley, Simon Stanworth, Karen A. Willoughby, Susanna F. Fustolo‐Gunnink, Vidheya Venkatesh, Cara Hudson, Alison Deary, Renate Hodge, Valerie Hopkins, (unknown), Ana Sabrina Mora, Charlotte Llewelyn, Angela D’Amore, Rizwan Khan, Wes Onland, Enrico Lopriore, Karin Fijnvandraat, (unknown), Paul Clarke, Timothy J. Watts	249
9	The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial 2013 ·The Lancet ·Jo Howard, (unknown), Charlotte Llewelyn, Louise Choo, Renate Hodge, Tony Johnson, (unknown), David C. Rees, (unknown), Isabeau Walker, Karin Fijnvandraat, Melanie Kirby‐Allen, Eldon Spackman, Sally C. Davies, Lorna M. Williamson	152
10	Cost‐effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial 2013 ·European Journal Of Haematology ·Eldon Spackman, Mark Sculpher, Jo Howard, (unknown), Charlotte Llewelyn, Louise Choo, Renate Hodge, Tony Johnson, David C. Rees, Karin Fijnvandraat, Melanie Kirby‐Allen, Sally C. Davies, Lorna M. Williamson	10
11	Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial 2011 ·Blood ·Jo Howard, (unknown), (unknown), Louise Choo, David C. Rees, Isabeau Walker, Tony Johnson, (unknown), Karin Fijnvandraat, Melanie Kirby‐Allen, Renate Hodge, (unknown), Sally C. Davies, Lorna M. Williamson	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact